Retatrutide - Top-Line Results from TRIUMPH 4

In this quick update, I break down the newest Phase 3 data for retatrutide, Lilly’s investigational triple-agonist medication showing unprecedented results in obesity and knee osteoarthritis. Highlights: Up to 28.7% weight loss (~71 lbs) over 68 weeks 75% reduction in knee pain and major improvements in physical function Cardiometabolic benefits: lower triglycerides, non-HDL cholesterol, hsCRP, and blood pressure We also cover Common side effects and safety signals Perceived excessive weight loss — and what this means for clinical practice in a new era of powerful medications A reality check on Canadian availability (likely 3+ years away) A strong warning about illegal online sales and the risks of buying unregulated products A concise medical breakdown to help you stay informed and safe as the obesity-medicine landscape evolves.

You can listen to Retatrutide - Top-Line Results from TRIUMPH 4 online on Radio and Podcast. Open the player on this page to stream the available audio.

Retatrutide - Top-Line Results from TRIUMPH 4 is an episode from High on Life by Sasha High.

This episode is 6:33 long.

This episode was published on Dec 11, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from High on Life when more episodes are available from the podcast feed.